로피나비르 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "로피나비르" in Korean language version.

refsWebsite

Global rank Korean rank

2^nd place

3^rd place

4^th place

4^th place

447^th place

433^rd place

1books.google.com

3^rd place

9^th place

low place

low place

1semanticscholar.org

11^th place

310^th place

1manchester.ac.uk

4,003^rd place

8,418^th place

1web.archive.org

1^st place

1^st place

books.google.com

Fischer, Jnos; Ganellin, C. Robin (2006). 《Analogue-based Drug Discovery》. John Wiley & Sons. 510쪽. ISBN 9783527607495.

doi.org

dx.doi.org

Capparelli E, Holland D, Okamoto C, 외. (2005). “Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV”. 《AIDS》 19 (9): 949–52. doi:10.1097/01.aids.0000171409.38490.48. PMID 15905676. S2CID 3162858.
Cao, Bin; Wang, Yeming; Wen, Danning; Liu, Wen; Wang, Jingli; Fan, Guohui; 외. (2020년 3월 18일). “A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19”. 《New England Journal of Medicine》 382 (19): 1787–1799. doi:10.1056/NEJMoa2001282. PMC 7121492. PMID 32187464.
de Wilde, Adriaan H.; Jochmans, Dirk; Posthuma, Clara C.; Zevenhoven-Dobbe, Jessika C.; van Nieuwkoop, Stefan; Bestebroer, Theo M.; 외. (August 2014). “Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture”. 《Antimicrobial Agents and Chemotherapy》 58 (8): 4875–4884. doi:10.1128/AAC.03011-14. PMC 4136071. PMID 24841269.

fda.gov

accessdata.fda.gov

“FDA Approved Drug Products: Kaletra”. 2004년 4월 30일에 확인함.

manchester.ac.uk

HIV drug used to reverse effects of virus that causes cervical cancer Archived 2014년 3월 22일 - 웨이백 머신 University of Manchester, 17 February 2014.

nih.gov

ncbi.nlm.nih.gov

Capparelli E, Holland D, Okamoto C, 외. (2005). “Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV”. 《AIDS》 19 (9): 949–52. doi:10.1097/01.aids.0000171409.38490.48. PMID 15905676. S2CID 3162858.
Cao, Bin; Wang, Yeming; Wen, Danning; Liu, Wen; Wang, Jingli; Fan, Guohui; 외. (2020년 3월 18일). “A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19”. 《New England Journal of Medicine》 382 (19): 1787–1799. doi:10.1056/NEJMoa2001282. PMC 7121492. PMID 32187464.
de Wilde, Adriaan H.; Jochmans, Dirk; Posthuma, Clara C.; Zevenhoven-Dobbe, Jessika C.; van Nieuwkoop, Stefan; Bestebroer, Theo M.; 외. (August 2014). “Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture”. 《Antimicrobial Agents and Chemotherapy》 58 (8): 4875–4884. doi:10.1128/AAC.03011-14. PMC 4136071. PMID 24841269.

rxabbott.com

Kaletra (lopinavir/ritonavir) capsules; (lopinavir/ritonavir) oral solution. Prescribing information. April 2009

semanticscholar.org

api.semanticscholar.org

Capparelli E, Holland D, Okamoto C, 외. (2005). “Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV”. 《AIDS》 19 (9): 949–52. doi:10.1097/01.aids.0000171409.38490.48. PMID 15905676. S2CID 3162858.

web.archive.org

HIV drug used to reverse effects of virus that causes cervical cancer Archived 2014년 3월 22일 - 웨이백 머신 University of Manchester, 17 February 2014.